{"id":"https://openalex.org/W4400564993","doi":"https://doi.org/10.1007/s40263-024-01095-y","title":"Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022","display_name":"Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022","alternate_titles":[],"publication_year":2024,"publication_date":"2024-07-11","ids":{"openalex":"https://openalex.org/W4400564993","doi":"https://doi.org/10.1007/s40263-024-01095-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/38990472"},"language":"en","primary_location":{"id":"doi:10.1007/s40263-024-01095-y","doi":"https://doi.org/10.1007/s40263-024-01095-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40263-024-01095-y","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4400564993"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hal.science/hal-04976647v1/document","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111254789","display_name":"Cl\u00e9ment Garnier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210110495","display_name":"Institut de Neurosciences des Syst\u00e8mes","ror":"https://ror.org/019kqby73","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210110495"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cl\u00e9ment Garnier","raw_affiliation_strings":["D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 des Sciences M\u00e9dicales et param\u00e9dicales, Marseille, France","Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 des Sciences M\u00e9dicales et param\u00e9dicales, Marseille, France","institution_ids":["https://openalex.org/I21491767"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210110495"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Martin Schein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210110495","display_name":"Institut de Neurosciences des Syst\u00e8mes","ror":"https://ror.org/019kqby73","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210110495"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Schein","raw_affiliation_strings":["D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 des Sciences M\u00e9dicales et param\u00e9dicales, Marseille, France","Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 des Sciences M\u00e9dicales et param\u00e9dicales, Marseille, France","institution_ids":["https://openalex.org/I21491767"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210110495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080005685","display_name":"Cl\u00e9mence Lacroix","orcid":"https://orcid.org/0000-0002-6857-4698","observed_orcids":["https://orcid.org/0000-0002-6857-4698"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210110495","display_name":"Institut de Neurosciences des Syst\u00e8mes","ror":"https://ror.org/019kqby73","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210110495"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cl\u00e9mence Lacroix","raw_affiliation_strings":["Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France"],"raw_orcid":"https://orcid.org/0000-0002-6857-4698","affiliations":[{"raw_affiliation_string":"Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210110495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080749949","display_name":"\u00c9lisabeth Jouve","orcid":"https://orcid.org/0000-0002-4873-6522","observed_orcids":["https://orcid.org/0000-0002-4873-6522"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210110495","display_name":"Institut de Neurosciences des Syst\u00e8mes","ror":"https://ror.org/019kqby73","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210110495"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisabeth Jouve","raw_affiliation_strings":["Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France"],"raw_orcid":"https://orcid.org/0000-0002-4873-6522","affiliations":[{"raw_affiliation_string":"Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210110495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028301874","display_name":"Thomas Soeiro","orcid":"https://orcid.org/0000-0003-2604-9673","observed_orcids":["https://orcid.org/0000-0003-2604-9673"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210110495","display_name":"Institut de Neurosciences des Syst\u00e8mes","ror":"https://ror.org/019kqby73","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210110495"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Soeiro","raw_affiliation_strings":["Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France"],"raw_orcid":"https://orcid.org/0000-0003-2604-9673","affiliations":[{"raw_affiliation_string":"Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210110495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049476937","display_name":"Ga\u00ebtan Gentile","orcid":"https://orcid.org/0000-0002-8849-7888","observed_orcids":["https://orcid.org/0000-0002-8849-7888"]},"institutions":[{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ga\u00e9tan Gentile","raw_affiliation_strings":["D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 des Sciences M\u00e9dicales et param\u00e9dicales, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 des Sciences M\u00e9dicales et param\u00e9dicales, Marseille, France","institution_ids":["https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050870063","display_name":"Maryse Lapeyre\u2010Mestre","orcid":"https://orcid.org/0000-0002-5494-5873","observed_orcids":["https://orcid.org/0000-0002-5494-5873"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4387156050","display_name":"Centre d\u2019Investigation Clinique 1436","ror":"https://ror.org/033z83z59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maryse Lapeyre Mestre","raw_affiliation_strings":["Service de Pharmacologie M\u00e9dicale et Clinique, UFR Sant\u00e9 Universit\u00e9 de Toulouse - Paul Sabatier, CEIP-Addictovigilance de Toulouse, CHU de Toulouse, CIC 1436, 31000, Toulouse, France"],"raw_orcid":"https://orcid.org/0000-0002-5494-5873","affiliations":[{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique, UFR Sant\u00e9 Universit\u00e9 de Toulouse - Paul Sabatier, CEIP-Addictovigilance de Toulouse, CHU de Toulouse, CIC 1436, 31000, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I3019448017","https://openalex.org/I4387156050","https://openalex.org/I4405258862"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016176687","display_name":"Jo\u00eblle Micallef","orcid":"https://orcid.org/0000-0002-7172-7835","observed_orcids":["https://orcid.org/0000-0002-7172-7835"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210134195","display_name":"H\u00f4pital Sainte-Marguerite","ror":"https://ror.org/0338wkj94","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jo\u00eblle Micallef","raw_affiliation_strings":["Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France. joelle.micallef@ap-hm.fr"],"raw_orcid":"https://orcid.org/0000-0002-7172-7835","affiliations":[{"raw_affiliation_string":"Service de Pharmacologie Clinique et Pharmacosurveillance, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, 270 boulevard Sainte Marguerite, 13009, Marseille, France. joelle.micallef@ap-hm.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5016176687"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210134195"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.2132,"has_fulltext":true,"cited_by_count":12,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92394133,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"38","issue":"9","first_page":"743","last_page":"751"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.7333999872207642,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.7333999872207642,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.25270000100135803,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":0.8389999866485596},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.414000004529953},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.7829999923706055},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.7049999833106995},{"id":"https://openalex.org/keywords/illicit-drug-use","display_name":"illicit drug use","score":0.47200000286102295},{"id":"https://openalex.org/keywords/street-markets","display_name":"street markets","score":0.367000013589859},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.6389999985694885},{"id":"https://openalex.org/keywords/user-profiles","display_name":"user profiles","score":0.6240000128746033},{"id":"https://openalex.org/keywords/france","display_name":"France","score":0.44200000166893005},{"id":"https://openalex.org/keywords/temporal-trends","display_name":"temporal trends","score":0.4959999918937683},{"id":"https://openalex.org/keywords/precarity","display_name":"precarity","score":0.5389999747276306},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.4009999930858612},{"id":"https://openalex.org/keywords/benzodiazepine-misuse","display_name":"benzodiazepine misuse","score":0.5590000152587891},{"id":"https://openalex.org/keywords/gabapentinoids","display_name":"gabapentinoids","score":0.4869999885559082},{"id":"https://openalex.org/keywords/harm-reduction","display_name":"harm reduction","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.8786319494247437},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.6350350379943848},{"id":"https://openalex.org/C103709681","wikidata":"https://www.wikidata.org/wiki/Q1515727","display_name":"Psychopharmacology","level":2,"score":0.6070138216018677},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5256977081298828},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4928026497364044},{"id":"https://openalex.org/C2992025106","wikidata":"https://www.wikidata.org/wiki/Q1260022","display_name":"Substance abuse treatment","level":3,"score":0.44767487049102783},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33158186078071594}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016320","descriptor_name":"Substance Abuse Treatment Centers","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s40263-024-01095-y","doi":"https://doi.org/10.1007/s40263-024-01095-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40263-024-01095-y","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},{"id":"pmid:38990472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38990472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drugs","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04976647v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-04976647","pdf_url":"https://hal.science/hal-04976647v1/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CNS Drugs, 2024, 38 (9), pp.743-751. &#x27E8;10.1007/s40263-024-01095-y&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:HAL:hal-04976647v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-04976647","pdf_url":"https://hal.science/hal-04976647v1/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CNS Drugs, 2024, 38 (9), pp.743-751. &#x27E8;10.1007/s40263-024-01095-y&#x27E9;","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400564993.pdf","grobid_xml":"https://content.openalex.org/works/W4400564993.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1513618424","https://openalex.org/W1965579959","https://openalex.org/W1977980816","https://openalex.org/W1987748737","https://openalex.org/W2026520783","https://openalex.org/W2029472930","https://openalex.org/W2043515921","https://openalex.org/W2058884859","https://openalex.org/W2061126722","https://openalex.org/W2064186732","https://openalex.org/W2065417208","https://openalex.org/W2065463534","https://openalex.org/W2066787172","https://openalex.org/W2090489905","https://openalex.org/W2160521327","https://openalex.org/W2473719585","https://openalex.org/W2590306277","https://openalex.org/W2759493615","https://openalex.org/W2913431088","https://openalex.org/W2943829329","https://openalex.org/W2979889178","https://openalex.org/W2985547232","https://openalex.org/W2991917985","https://openalex.org/W3082083289","https://openalex.org/W3082895188","https://openalex.org/W3128459417","https://openalex.org/W3139142429","https://openalex.org/W3197754693","https://openalex.org/W3210557611","https://openalex.org/W3215529611","https://openalex.org/W4200481318","https://openalex.org/W4220966788","https://openalex.org/W4283066106","https://openalex.org/W4283071004","https://openalex.org/W4377093462","https://openalex.org/W4385670273"],"related_works":["https://openalex.org/W4404650938","https://openalex.org/W7014873995","https://openalex.org/W7214431303","https://openalex.org/W4403191081","https://openalex.org/W2759493615","https://openalex.org/W2757130267","https://openalex.org/W7154627603","https://openalex.org/W2220840316","https://openalex.org/W2805120311","https://openalex.org/W4401690549"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4400564993","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2024-07-12T00:00:00"}
